How have DWTX and TELA total returns compared?

Over the past 5 years, DWTX delivered -58.44% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.

Dogwood Therapeutics, Inc. (DWTX) vs TELA Bio, Inc. (TELA)

A side-by-side comparison of Dogwood Therapeutics, Inc. and TELA Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DWTX

Dogwood Therapeutics, Inc.

$54M

$1.60HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT

TELA

TELA Bio, Inc.

$49M

$1.10HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT

Total return — DWTX vs TELA

growth of $100 · dividends reinvested · last 6y

DWTX -99.6% (-60.8%/yr)TELA -93.0% (-35.8%/yr)TELA compounded faster over this window

Log scale — wide-divergence pair

DWTX TELA

DWTX vs TELA: by the numbers

•DWTX is the larger company ($54M vs $49M market cap).
•Both run net losses; DWTX's is the smaller (0.00% vs -51.53% net margin).

Metrics side by side

Valuation

Metric	DWTX	TELA
P/S ratio	N/A	0.61
P/B ratio	0.79	N/A

Profitability

Metric	DWTX	TELA
Gross margin	0.00%	67.81%
Operating margin	0.00%	-42.56%
Net margin	0.00%	-51.53%
ROE	-52.72%	N/A
ROIC	-38.04%	-80.88%

Growth (annualized)

Metric	DWTX	TELA
Revenue CAGR (5Y)	N/A	26.77%
Total return CAGR (5Y)	-58.44%	-38.71%

Frequently asked

How have DWTX and TELA total returns compared?: Over the past 5 years, DWTX delivered -58.44% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DWTX analysis Full TELA analysis Interactive comparison tool

Dig into the metrics

Dogwood Therapeutics ROE TELA Bio ROE Dogwood Therapeutics operating margin TELA Bio operating margin Dogwood Therapeutics revenue growth TELA Bio revenue growth Dogwood Therapeutics free cash flow TELA Bio free cash flow

Dogwood Therapeutics & TELA Bio appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.